Markets · Global Equities · US
ACADIA PHARMACEUTICALS INC ACAD
Exchange Nasdaq. Sector Pharma & biotech. Source: SEC companyfacts. Not a price feed.
- Revenue TTM 1.20B
- EBITDA TTM 141.86M
- Net debt -405.37M
- ND/EBITDA -2.86
- EBITDA/interest —
- ROE 0.12
- Implied band BBB